StockWatch
·
Pharmaceuticals
Quarterly Result29 May 2026, 06:53 pm

Triochem Products Approves FY26 Financial Results

AI Summary

Triochem Products Ltd held a board meeting on May 29, 2026, and approved the annual financial statements for the year ended March 31, 2026. The board also approved the audited financial results for the quarter and year ended March 31, 2026. The company recognized a gain of ₹1,116.65 lakhs as an exceptional item from the sale of assets. The company's operations were impacted by the Covid-19 pandemic, but the management believes there are no material adjustments required in the financial statements.

Key Highlights

  • Board approved FY26 audited financial results.
  • Gain of ₹1,116.65 lakhs recognized from asset sales.
  • Covid-19 pandemic impacted operations; no material adjustments needed.
  • Sale proceeds to fund new business ventures.